Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants
摘要:
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are key elements of multidrug regimens, called HAART (Highly Active Antiretroviral Therapy), that are used to treat HIV-1 infections. Elucidation of the structure-activity relationships of the thiocarbamate moiety of the previous published lead compound 2 provided a series of novel tetrahydroquinoline derivatives as potent inhibitors of HIV-1 RT with nanomolar intrinsic activity on the WT and key mutant enzymes and potent antiviral activity in infected cells. The SAR optimization, mutation profiles, preparation of compounds, and pharmacokinetic profile of compounds are described. (C) 2009 Elsevier Ltd. All rights reserved.
Medium-Ring Nitrogen Heterocycles through Migratory Ring Expansion of Metalated Ureas
作者:Jessica E. Hall、Johnathan V. Matlock、John W. Ward、Katharine V. Gray、Jonathan Clayden
DOI:10.1002/anie.201605714
日期:2016.9.5
benzo‐fused nitrogen heterocycles (indolines, tetrahydroquinolines, and their homologues) undergo migratory ring expansion through deprotonation of their benzylic urea derivatives with lithium diisopropylamide (LDA) in the presence of N,N′‐dimethylpropylideneurea (DMPU). The products of the reactions are benzodiazepines, benzodiazocines, and their homologues, with ring sizes of 8–12. The reactions tolerate a
Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants
作者:Dai-Shi Su、John J. Lim、Elizabeth Tinney、Bang-Lin Wan、Mary Beth Young、Kenneth D. Anderson、Deanne Rudd、Vandna Munshi、Carolyn Bahnck、Peter J. Felock、Meiqing Lu、Ming-Tain Lai、Sinoeun Touch、Gregory Moyer、Daniel J. DiStefano、Jessica A. Flynn、Yuexia Liang、Rosa Sanchez、Sridhar Prasad、Youwei Yan、Rebecca Perlow-Poehnelt、Maricel Torrent、Mike Miller、Joe P. Vacca、Theresa M. Williams、Neville J. Anthony
DOI:10.1016/j.bmcl.2009.07.031
日期:2009.9
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are key elements of multidrug regimens, called HAART (Highly Active Antiretroviral Therapy), that are used to treat HIV-1 infections. Elucidation of the structure-activity relationships of the thiocarbamate moiety of the previous published lead compound 2 provided a series of novel tetrahydroquinoline derivatives as potent inhibitors of HIV-1 RT with nanomolar intrinsic activity on the WT and key mutant enzymes and potent antiviral activity in infected cells. The SAR optimization, mutation profiles, preparation of compounds, and pharmacokinetic profile of compounds are described. (C) 2009 Elsevier Ltd. All rights reserved.